In summary, our study demonstrated that carriers of the MTTP 297H significantly had lower apoB-containing lipoproteins (LDL-C, non-HDL-C) and greater risk of NAFLD adjusted by age, sex and insulin resistance. This evidence concerns the gene APOB and metabolic dysfunction-associated steatotic liver disease.